Impact of loss-of-function in angiopoietin-like 4 on the human phenome
CONCLUSIONS: ANGPTL4 inhibition may represent a potentially safe and effective target for cardiometabolic diseases prevention or treatment.PMID:38703417 | DOI:10.1016/j.atherosclerosis.2024.117558
Source: Atherosclerosis - Category: Cardiology Authors: Eloi Gagnon J érome Bourgault Émilie Gobeil S ébastien Thériault Benoit J Arsenault Source Type: research
More News: Cardiology | Diabetes | Diabetes Type 2 | Electronic Health Records (EHR) | Endocrinology | Genetics | Heart | Men | Study